Last Price$19.1(7.5%)
Market Cap$14.6B
(3,335.4%)
Industry median - (83.9%)
5Y Historical average - (1,418.7%)
(3,343.2%)
Industry median - (90.6%)
5Y Historical average - (1,424.6%)
(53.5%)
Industry median - (33.9%)
5Y Historical average - (184.3%)
(51.1%)
Industry median - (34.0%)
5Y Historical average - (113.1%)
SMMT Capital Allocation Rating
SMMT Capital Allocation rating
4.5
SMMT Capital Allocation rating performance
SMMT Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with SMMT Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$14.6B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$402.0B | 6.1 | 35.5% | 28.0% | 24.3% | 76.5% | 46.8% | (1.0%) | 2.2% | |
$125.5B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$74.0B | 6.2 | 25.0% | 17.4% | 24.6% | 13.7% | 10.3% | 1.4% | 4.3% | |
$38.1B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$31.3B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$27.1B | 5.2 | (41.4%) | (48.4%) | 37.5% | (1.7%) | (5.5%) | (0.8%) | 0.0% | |
$15.2B | 5.1 | 14.5% | 6.7% | 37.0% | 0.0% | 6.2% | (2.8%) | 3.6% | |
$14.8B | 4.9 | (12.7%) | (20.5%) | 13.4% | 1.0% | (6.1%) | (14.1%) | 13.6% | |
$14.0B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.2% | |
$1,846.9M | 4.3 | (38.4%) | (45.1%) | (41.5%) | (25.3%) | (24.7%) | 0.0% | 0.0% |
FAQ
What is the Summit Therapeutics Inc. (SMMT) ROIC (Return on Invested Capital)?
The Summit Therapeutics Inc. (SMMT) ROIC is (3,335.4%), compared to the industry median of ((83.9%)) and the 5-year historical average of (1,418.7%).
What is the Summit Therapeutics Inc. (SMMT) ROIC minus WACC (Weighted Average Cost of Capital)?
The Summit Therapeutics Inc. (SMMT) ROIC minus WACC is (3,343.2%), compared to the industry median of ((90.6%)) and the 5-year historical average of (1,424.6%).
What is the Summit Therapeutics Inc. (SMMT) ROE (Return on Equity)?
The Summit Therapeutics Inc. (SMMT) ROE is (53.5%), compared to the industry median of ((33.9%)) and the 5-year historical average of (184.3%).
What is the Summit Therapeutics Inc. (SMMT) ROCE (Return on Capital Employed)?
The Summit Therapeutics Inc. (SMMT) ROCE is (51.1%), compared to the industry median of ((34.0%)) and the 5-year historical average of (113.1%).